AtriCure, Inc. (ATRC) is a publicly traded Healthcare sector company. As of July 24, 2026, ATRC trades at $32.13 with a market cap of $1.70B and a P/E ratio of -330.12. ATRC moved -1.54% today. Year to date, ATRC is -16.58%; over the trailing twelve months it is +7.07%. Its 52-week range spans $25.36 to $43.18. Analyst consensus is strong buy with an average price target of $49.00. Rallies surfaces ATRC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for ATRC, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $32.13 |
| Market Cap | $1.70B |
| P/E Ratio | -330.12 |
| EPS | $-0.10 |
| Dividend Yield | 0.00% |
| 52-Week High | $43.18 |
| 52-Week Low | $25.36 |
| Volume | 1.00M |
| Avg Volume | 0 |
| Revenue (TTM) | $552.16M |
| Net Income | $-4.59M |
| Gross Margin | 75.61% |
5 analysts cover ATRC: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $49.00.